Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2020 Oct 27

PMID 33105816

Citations 26

Authors

Mohamadreza Amin

Wenqiu Huang

Ann L B Seynhaeve

Timo L M Ten Hagen

Affiliations

Soon will be listed here.

Abstract

Nanotechnology has great capability in formulation, reduction of side effects, and enhancing pharmacokinetics of chemotherapeutics by designing stable or long circulating nano-carriers. However, effective drug delivery at the cellular level by means of such carriers is still unsatisfactory. One promising approach is using spatiotemporal drug release by means of nanoparticles with the capacity for content release triggered by internal or external stimuli. Among different stimuli, interests for application of external heat, hyperthermia, is growing. Advanced technology, ease of application and most importantly high level of control over applied heat, and as a result triggered release, and the adjuvant effect of hyperthermia in enhancing therapeutic response of chemotherapeutics, i.e., thermochemotherapy, make hyperthermia a great stimulus for triggered drug release. Therefore, a variety of temperature sensitive nano-carriers, lipid or/and polymeric based, have been fabricated and studied. Importantly, in order to achieve an efficient therapeutic outcome, and taking the advantages of thermochemotherapy into consideration, release characteristics from nano-carriers should fit with applicable clinical thermal setting. Here we introduce and discuss the application of the three most studied temperature sensitive nanoparticles with emphasis on release behavior and its importance regarding applicability and therapeutic potentials.

Citing Articles

Ultrasound-triggered drug release and cytotoxicity of microbubbles with diverse drug attributes.

Chuang C, Lin C, Yeh C Ultrason Sonochem. 2024; 112():107182.

PMID: 39631357 PMC: 11655813. DOI: 10.1016/j.ultsonch.2024.107182.

Effective Use of DCM Root Extract Encapsulated by Thermosensitive Immunoliposomes for Targeted Drug Delivery in Prostate Cancer Cells.

Riet K, Adegoke A, Mashele S, Sekhoacha M Curr Issues Mol Biol. 2024; 46(11):12037-12060.

PMID: 39590308 PMC: 11593239. DOI: 10.3390/cimb46110714.

Form Equals Function: Influence of Coacervate Architecture on Drug Delivery Applications.

Lim C, Blocher McTigue W ACS Biomater Sci Eng. 2024; 10(11):6766-6789.

PMID: 39423330 PMC: 11558567. DOI: 10.1021/acsbiomaterials.4c01105.

Magnetic-vortex nanodonuts enhance ferroptosis effect of tumor ablation through an imaging-guided hyperthermia/radiosensitization strategy.

Guo S, Chen M, Yang Y, Zhang Y, Pang X, Shi Y iScience. 2024; 27(10):110533.

PMID: 39398248 PMC: 11467572. DOI: 10.1016/j.isci.2024.110533.

Lipid-based nanosystems: the next generation of cancer immune therapy.

Cheng Z, Fobian S, Gurrieri E, Amin M, DAgostino V, Falahati M J Hematol Oncol. 2024; 17(1):53.

PMID: 39030582 PMC: 11265205. DOI: 10.1186/s13045-024-01574-1.

References

Wang X, Li S, Wan Z, Quan Z, Tan Q . Investigation of thermo-sensitive amphiphilic micelles as drug carriers for chemotherapy in cholangiocarcinoma in vitro and in vivo. Int J Pharm. 2014; 463(1):81-8. DOI: 10.1016/j.ijpharm.2013.12.046. View

Issels R, Lindner L, Verweij J, Wust P, Reichardt P, Schem B . Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010; 11(6):561-70. PMC: 3517819. DOI: 10.1016/S1470-2045(10)70071-1. View

Bhakay A, Rahman M, Dave R, Bilgili E . Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges. Pharmaceutics. 2018; 10(3). PMC: 6160929. DOI: 10.3390/pharmaceutics10030086. View

Papahadjopoulos D, Jacobson K, Nir S, Isac T . Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim Biophys Acta. 1973; 311(3):330-48. DOI: 10.1016/0005-2736(73)90314-3. View

Akimoto J, Nakayama M, Sakai K, Okano T . Thermally controlled intracellular uptake system of polymeric micelles possessing poly(N-isopropylacrylamide)-based outer coronas. Mol Pharm. 2010; 7(4):926-35. DOI: 10.1021/mp100021c. View

Tagami T, Ernsting M, Li S . Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release. 2011; 152(2):303-9. DOI: 10.1016/j.jconrel.2011.02.009. View

Gabizon A, Shmeeda H, Barenholz Y . Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003; 42(5):419-36. DOI: 10.2165/00003088-200342050-00002. View

Senapati S, Mahanta A, Kumar S, Maiti P . Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018; 3:7. PMC: 5854578. DOI: 10.1038/s41392-017-0004-3. View

Han H, Shin B, Choi H . Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum. Eur J Pharm Biopharm. 2005; 62(1):110-6. DOI: 10.1016/j.ejpb.2005.07.006. View

10.

Nittayacharn P, Yuan H, Hernandez C, Bielecki P, Zhou H, Exner A . Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles. J Pharm Sci. 2019; 108(9):3091-3098. PMC: 6708467. DOI: 10.1016/j.xphs.2019.05.004. View

11.

Killock D . Sarcoma: Local hyperthermia improves survival. Nat Rev Clin Oncol. 2018; 15(5):266. DOI: 10.1038/nrclinonc.2018.38. View

12.

Minchinton A, Tannock I . Drug penetration in solid tumours. Nat Rev Cancer. 2006; 6(8):583-92. DOI: 10.1038/nrc1893. View

13.

Kokuryo D, Nakashima S, Ozaki F, Yuba E, Chuang K, Aoshima S . Evaluation of thermo-triggered drug release in intramuscular-transplanted tumors using thermosensitive polymer-modified liposomes and MRI. Nanomedicine. 2014; 11(1):229-38. DOI: 10.1016/j.nano.2014.09.001. View

14.

Kong G, Braun R, Dewhirst M . Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 2001; 61(7):3027-32. View

15.

Harrington K, Mohammadtaghi S, Uster P, Glass D, Peters A, Vile R . Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 2001; 7(2):243-54. View

16.

Tan Q, Saggar J, Yu M, Wang M, Tannock I . Mechanisms of Drug Resistance Related to the Microenvironment of Solid Tumors and Possible Strategies to Inhibit Them. Cancer J. 2015; 21(4):254-62. DOI: 10.1097/PPO.0000000000000131. View

17.

Paasonen L, Romberg B, Storm G, Yliperttula M, Urtti A, Hennink W . Temperature-sensitive poly(N-(2-hydroxypropyl)methacrylamide mono/dilactate)-coated liposomes for triggered contents release. Bioconjug Chem. 2007; 18(6):2131-6. DOI: 10.1021/bc700245p. View

18.

Northfelt D, Martin F, Working P, Volberding P, Russell J, Newman M . Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol. 1996; 36(1):55-63. DOI: 10.1002/j.1552-4604.1996.tb04152.x. View

19.

Todryk S, Melcher A, Hardwick N, Linardakis E, Bateman A, Colombo M . Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol. 1999; 163(3):1398-408. View

20.

Griffin R, Ogawa A, Williams B, Song C . Hyperthermic enhancement of tumor radiosensitization strategies. Immunol Invest. 2005; 34(3):343-59. DOI: 10.1081/imm-200066270. View